MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm15093409

Медицинская библиотека · Journal of clinical medicine · 2026

Serum CD93 as a Potential Diagnostic Biomarker for Endometrial Cancer: A Case-Control Study.

Bağlar İsmail, Şanlıkan Fatih, Keles Esra, Kara Sahra Sultan, Özdaş Cansu Ergenç, Dönmez Yeliz Çeçen, Uzun Hafize

СтатьяПеревод в очереди

Аннотация

Objectives

CD93, an angiogenesis-related transmembrane glycoprotein, is transcriptomically downregulated in uterine corpus endometrial carcinoma, yet circulating protein levels have not been clinically evaluated. This study aimed to evaluate serum CD93 as a diagnostic biomarker for EC and to examine its association with clinicopathological parameters.

Methods

In this single-center case-control study, serum CD93 concentrations were measured by enzyme-linked immunosorbent assay in 46 patients with histologically confirmed primary EC and 35 controls with histologically verified benign gynecological pathology. Logistic regression and receiver operating characteristic (ROC) curve analyses were performed.

Results

Serum CD93 was significantly lower in EC patients than controls (median 4.55 [IQR 3.51-6.97] vs. 10.24 [7.18-12.14] ng/mL; p < 0.001). In multivariable analysis adjusted for age and body mass index, lower CD93 remained independently associated with EC (OR = 0.521; 95% CI 0.061-0.720; p < 0.001). ROC analysis yielded an area under the curve of 0.845 (95% CI 0.759-0.921), with 82.6% sensitivity and 74.3% specificity at a cut-off of 7.338 ng/mL. CD93 levels showed no significant association with histological subtype, grade, lymphovascular space invasion, nodal metastasis, or recurrence.

Conclusions

Serum CD93 is significantly reduced in EC and demonstrates independent diagnostic performance, supporting its prospective validation as a non-invasive biomarker in larger multicenter cohorts.

Для цитирования: Bağlar İsmail, Şanlıkan Fatih, Keles Esra, Kara Sahra Sultan, Özdaş Cansu Ergenç, Dönmez Yeliz Çeçen, Uzun Hafize. Serum CD93 as a Potential Diagnostic Biomarker for Endometrial Cancer: A Case-Control Study.. Journal of clinical medicine. 2026. DOI: 10.3390/jcm15093409.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.